About Psilos Group
Psilos Group is a venture capital firm founded in 1998. It is primarily based out of New York City, United States. As of Sep 2017, Psilos Group has invested in 27 companies. It primarily invests in Series B round in United States based startups. Its investments are spread across a wide range of sectors from HealthTech to Life Sciences and Enterprise Applications. Most recently it participated in the $***** Series D round of PatientSafe Solutions Overall, Psilos Group portfolio has seen 2 IPOs and 16 acquisitions including key companies like HealthEdge, Best Doctors and Health Hero Network. A lot of funds co-invest with Psilos Group, with names like Shoreline Venture Management sharing a substantial percentage of its portfolio. Psilos Group has team of 2 people including 2 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series B, Series A & 4 more
Portfolio IPOs
Portfolio Acquisitions
Psilos Group's List of Top Investments
Psilos Group has a portfolio of 27 companies. Their most notable investments are in Cohesive Technologies and HealthMine.Their portfolio spans across United States, Australia, France and 2 more locations. They have invested in HealthTech, Life Sciences, Enterprise Applications and 7 other sectors, across stages such as Series B, Series A and 4 more. Here is the list of top investments by Psilos Group:1. HealthEdge
HealthEdge provides a suite of software products for the healthcare payer market. Suite platform HealthRules is delivered to customers via the HealthEdge Cloud or on-site deployment. The suite includes claims and benefits administration, care management, business intelligence, and portal solutions designed to empower healthcare payers to capitalize on innovations and opportunities that await them in the new healthcare economy.
Key facts about HealthEdge
- Founded Year: 2004
- Location: Burlington (United States)
- Stage: Acquired
- Total Funding till date: $108M
- Employee Count: 2,162 as on Mar 31, 2026
- Investors: Ardan Equity Partners, Golub Growth and 6 Others
- Latest Funding Round: Venture Debt, Jul 11, 2017, $*****
- Highlight: Acquired
2. HealthMine
Provider of technology and services for healthcare member engagement and quality. The company offers a platform to consolidate member engagement, risk, and quality initiatives. It facilitates personalized, omnichannel outreach and supports digital health risk assessments. The company also provides professional and expert advisory services.
Key facts about HealthMine
- Founded Year: 2008
- Location: San Francisco (United States)
- Stage: Series C
- Total Funding till date: $75M
- Employee Count: 23 as on Dec 31, 2021
- Investors: Saints Capital, Maverick Ventures and 4 Others
- Latest Funding Round: Series C, Jan 07, 2013, $*****
- Highlight: Editors' Pick
3. Best Doctors
Platform connects individuals with medical specialists to provide expert medical opinions. It provides second opinion solutions for employees to find right diagnosis and treatment. It offer access to medical experts and treating physicians to have a second opinion for diagnosis. It gives people immediate access to doctors and it also has a review system that helps to find out the doctors for the requirements. It also collect case records from the patients, images, and test samples.
Key facts about Best Doctors
- Founded Year: 1989
- Location: Boston (United States)
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $65.5M
- Employee Count: 5,500 as on Dec 31, 2024
- Investors: Echo Health Ventures, Nippon Life Insurance and 8 Others
- Latest Funding Round: PE, Aug 15, 2012, $*****
- Highlight: Acquired
Health Hero Network, currently part of Bosch Healthcare, provides technology solutions for remote health monitoring and management. The company provides health management programs delivering personalized daily monitoring and patient education, and information to care providers. It also offers Health Buddy system that serves as the interface between patients at home and care providers, facilitating patient education and monitoring of chronic conditions. The company's Health Buddy system includes monitoring technologies, clinical information databases, Internet-enabled decision support tools, health management programs, and content development software tools. It serves hospitals, health plans, government health organizations, disease management companies, and pharmaceutical companies or universities conducting clinical trials or studies.
Key facts about Health Hero Network
- Founded Year: 1988
- Location: London (United Kingdom)
- Stage: Acquired
- Total Funding till date: $34M
- Employee Count: 10 as on Dec 31, 2021
- Investors: Integral Capital Partners, KSV Global and 7 Others
- Latest Funding Round: Series B, Nov 17, 2006, $*****
- Highlight: Acquired
Mauna Kea Technologies produces devices for microscopic imaging during endoscopy procedures. Its tools allow surgeons to visualize, take biopsies, detect or rule out malignant or pre-malignant tumors or lesions in the gastrointestinal tract and pulmonary tracts. Their flagship product, Cellvizio, is a probe-based Confocal Laser Endomicroscopy (pCLE) system, that provides real-time access to histological images during standard endoscopy procedures through high-resolution cellular imaging of internal tissues. Cellvizio is cleared by FDA and has the European CE-Mark for use during digestive, pulmonary and urinary endoscopy procedures, including pancreatic and biliary endoscopic explorations as well as fine needle aspiration procedures. Mauna Kea Technologies also obtained clearance in China and Japan. Cellvizio went public in July 2011 and trades on the NYSE Euronext exchange.
Key facts about Mauna Kea Tech
- Founded Year: 2000
- Location: Paris (France)
- Stage: Public
- Total Funding till date: $30M
- Employee Count: 87 as on Jul 01, 2024
- Investors: Johnson & Johnson Innovation, Psilos Group and 7 Others
- Latest Funding Round: Post IPO, Nov 13, 2023, $*****
- Highlight: Public
Psilos Group's Investments by Stage
Psilos Group is primarily an Early Stage Investor investor majorly investing in Series B (11) rounds where average round size is $229M, Series A (2) rounds where average round size is $34M and Series C (2) rounds where average round size is $41.5M.Stage of entry | No. of Investments |
|---|---|
Series B | 11 |
Series A | 2 |
Series C | 2 |
Conventional Debt | 1 |
Seed | 1 |
Others | 1 |
Note: We have considered here, only first round of investments
Psilos Group's Investments by Sector
Psilos Group has a diverse portfolio, with companies operating in the Enterprise Applications, HealthTech, Life Sciences, Vertical SaaS and FinTech. Notably, it has invested in 21 Enterprise (B2B) companies, 20 Tech companies, 13 Software companies and at least 8 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Enterprise Applications | 8 |
HealthTech | 8 |
Life Sciences | 8 |
Vertical SaaS | 3 |
FinTech | 2 |
Others | 7 |
Note: We have considered here, only first round of investments
Psilos Group's Investments by Geography
Psilos Group has made most investments in United States (16), followed by France where it has made 1 investment.Country | No. of Investments |
|---|---|
United States | 16 |
France | 1 |
United Kingdom | 1 |
Note: We have considered here, only first round of investments
Psilos Group's recent investments
Psilos Group has not made any investment in 2026 so far.Here are the most recent investments by Psilos Group:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Sep 25, 2017 | United States | Series D | 7742 | [+3] | |
Oct 22, 2014 | United States | Series A | 6928 | - | |
Sep 24, 2013 | United States | Series C | 4505 | [+3] | |
Jul 10, 2013 | United States | Series A | 4560 | - | |
Jan 07, 2013 | United States | Series C | 4776 |
IPOs and Publicly Listed companies in Psilos Group's Portfolio
2 of Psilos Group's portfolio companies have become public. Mauna Kea Tech got listed on the Euronext Exchange (Euronext), in Aug 2023 at marketcap of undefined and Valera Pharmaceuticals got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ).Here are Psilos Group's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Aug 08, 2023 | Jan 23, 2008 | Series C | 2343 | |
Mar 27, 2017 | Aug 20, 2004 | Series C | 4968 |
Acquired companies in Psilos Group's Portfolio
16 companies from Psilos Group's portfolio have been acquired. The most recent acquisition were Caregiver Services in Oct 2024 by Help at Home.Here are Psilos Group's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Oct 23, 2024 | Aug 09, 2012 | Conventional Debt | 6288 | |
Apr 29, 2021 | Feb 08, 2010 | Series B | 2909 | |
Mar 09, 2020 | Apr 22, 2008 | Series B | 8597 | |
Jun 19, 2017 | - | - | 1091 | |
Apr 13, 2017 | 2008 | Seed | 9033 |
Team profile of Psilos Group
Psilos Group has a team of 2 members including 2 Partners located in United States. Psilos Group's team sits on the board of 1 company.Co-investors of Psilos Group
Over the past 28 years, 69 investors have co-invested in Psilos Group's portfolio companies. This includes only funds.
- Invested before Psilos Group: ESI, Argonaut Private Equity and 7 others have invested in rounds before Psilos Group. There is 1 company where ESI has invested before Psilos Group and 1 company where Argonaut Private Equity has invested before Psilos Group.
- Top Co-investors of Psilos Group: 29 investors entered a company along with Psilos Group. These include investors like Shoreline Venture Management (1 company).
- Invested after Psilos Group: A total of 31 investors have invested in Psilos Group's portfolio after their investments. Top Investors include Medica Health Plans (1 company), Horizon (1 company) and Fifth Street Asset Management (1 company).
Recent News related to Psilos Group
•
PatientSafe clinches $25M to expand operations, increase salesMobiHealthNews•Feb 11, 2018•PatientSafe Solutions, HighBar Partners, Merck Global Health Innovation Fund, Camden Partners and 3 others
•
Saints Capital is a leading direct secondary firmSaints Capital•Apr 20, 2011•AngioScore, Saints Capital, Psilos Group, Telegraph Hill Partners and 3 others
•
•
AngioScore Announces Completion of $30 Million Financing | Business WireBusiness Wire•Oct 09, 2007•AngioScore, Telegraph Hill Partners, Psilos Group, QuestMark Partners and 2 others
•
AngioScore, Inc. Announces Completion of $30 Million Financing | BioSpaceBioSpace•Oct 09, 2007•AngioScore, Telegraph Hill Partners, Psilos Group, QuestMark Partners and 2 others
•
Health Hero raises $16M for web-based home monitoring technology | VentureBeatVentureBeat•Nov 17, 2006•Health Hero Network, California Technology Ventures, Integral Capital Partners, Boston Scientific and 2 others
•
Health Hero Scores $16 Million - PE HubPE Hub•Nov 17, 2006•Health Hero Network, California Technology Ventures, Integral Capital Partners, Boston Scientific and 2 others
•
PE Week Wire - 8/1/06 - PE HubPE Hub•Oct 21, 2006•Veralight, Psilos Group, CMEA Ventures, Wasatch Advisors and 11 others
•
AngioScore Inc. Announces Completion of $30 Million Financing to Fund U.S. Product Launch | Business WireBusiness Wire•Apr 11, 2006•AngioScore, Telegraph Hill Partners, QuestMark Partners, Psilos Group and 2 others
•
PE Week Wire - Friday, October 8 - PE HubPE Hub•Oct 08, 2004•Critical Mention, Silicon Alley Venture Partners, Stonehenge Capital, Meyer and Co and 22 others
